Australia Becomes First Country to Approve Medical Use of MDMA and Psilocybin

Australia’s medical regulators have approved the use of MDMA and psilocybin, better known as magic mushrooms and ecstasy, to treat depression and post-traumatic stress disorder. The Therapeutic Goods Administration said it found “sufficient evidence for potential benefits in certain patients.” Psychiatrists would be able to prescribe the substances only after a thorough diagnosis, and their use would be restricted to clinical trials for now.